Профиль

Read the article: doi.org/10.1017/jme....

Join the Opioid Archive on Tuesday, August 18 at 1:00 pm ET (10:00 am PT) as we host a Q&A with Adriane Fugh-Berman and Judy Butler about their article using OIDA, "Redefining Pain and Addiction: How Opioid Manufacturers Changed Medical Language to Foster Opioid Use": jhjhm.zoom.us/webinar/regi...

Read the article: bmjopen.bmj.com/content/12/1...

Dorie Apollonio on “unbranded” opioid marketing to women and children. “These less visible, less regulated campaigns warrant closer scrutiny.” youtu.be/asgXvtCRlcI?...

The slide deck explores abuse deterrence studies and clinical trials of Vantrela: www.industrydocuments.ucsf.edu/docs/ffxx0333/

Images from a Teva presentation on Vantrela ER (extended-release hydrocodone bitartrate), comparing the results of crushing different kinds of tablets. See in #OIDAimages: images.oida-resources.jhu.edu/62be28ff-c67...

On Monday, July 20th, we’re back at IDL Office Hours offering expert archivist help. Bring your research questions & we’ll help you get started!  🗓️ Monday, July 20 from 11 – 12 p.m. Pacific Time On Zoom • live Q&A • not recorded 👉 Register at tiny.ucsf.edu/072026bluesky2 #Industrydocumentslibrary

For a deep dive of how tobacco companies continued to target specific cultural, ethnic, and gender identities, see www.industrydocuments.ucsf.edu/tobacco/more.... #FourthOfJuly #archives #tobaccoresearch

This July 1926 Camel cigarette ad was published in several magazines, urging readers to smoke and appreciate the "deepest goodness that ever came from a cigarette" while celebrating the 4th of July.

100 years ago, tobacco ads linked smoking and the 4th of July. “When Fourth of July bands are playing--and the cannon are roaring out of their celebration of another day of Independence and Freedom--have a Camel!” See the ads in IDL's archive at tiny.ucsf.edu/Lgcl5b and tiny.ucsf.edu/msdFCs

In June, we added 273K+ new opioid documents (Endo collection) and 1700+ tobacco documents (Juul collection). New feature: export saved documents’ metadata to .csv. Plus several new publications! Get all the news at tiny.ucsf.edu/EDVt6L #tobaccoresearch #endo #industrydocumentslibrary

New article alert! 📣 Check out a working paper by a team at Redgrave LLP that used a batch of Mallinckrodt #Opioid #Archive documents to examine "Generative AI for Complex Document Review." www.redgravellp.com/docs/default...

New paper alert! #FossilFuel industry’s historical awareness of global warming’s impacts on coral reefs explored using the Corporate Litigation and Accountability Research Assistant (CLARA), developed by the Climate Litigation Lab at Oxford. #LLM #archives doi.org/10.1038/s441...

If you have questions, you can join us on Monday, June 22 for office hours and expert archivist help. Emma James, the IDL archivist who led the project, will be there to answer questions. See URL above to register. #TobaccoControl #IndustryDocumentsLibrary

🔔 New: IDL Juul Labs Content Guide! We identified the most common topics and outlined ways to start your research. Juul-specific topics include nicotine, youth prevention, community outreach, flavors, leaking pods, workplace vaping, sales practices, and more. tiny.ucsf.edu/YcFT8Q #TobaccoResearch

If you have questions, you can join us on Monday, June 22 for office hours and expert archivist help. Emma James, the IDL archivist who led the project, will be there to answer questions. tiny.ucsf.edu/YcFT8Q #TobaccoResearch #TobaccoControl #IndustryDocumentsLibrary

We value your input! Take our survey and help shape our development of #Opioid #Archive research support tools: jh.qualtrics.com/jfe/form/SV_...

New #Opioid #Archive guide: Learn about Mallinckrodt's unsuccessful efforts to get abuse-deterrent labeling for their branded oxycodone/acetaminophen (Xartemis XR): www.industrydocuments.ucsf.edu/opioids/more...

...how Endo withdrew “crush-resistant” Opana ER from the market due to public health reports: www.industrydocuments.ucsf.edu/opioids/more... 5/5

...how Endo used OxyContin as a sales benchmark and its promotion of oxymorphone (Opana) for long-term use: www.industrydocuments.ucsf.edu/opioids/more... 4/5